Advisory Services Network’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$295K Buy
+36,301
New +$295K ﹤0.01% 1418
2024
Q1
Sell
-3,740
Closed -$22.4K 1666
2023
Q4
$22.4K Buy
+3,740
New +$22.4K ﹤0.01% 2469
2023
Q2
Sell
-4,740
Closed -$39.5K 1654
2023
Q1
$39.5K Buy
4,740
+1,500
+46% +$12.5K ﹤0.01% 2153
2022
Q4
$37.2K Buy
+3,240
New +$37.2K ﹤0.01% 2139
2021
Q3
Sell
-4,850
Closed -$77K 1562
2021
Q2
$77K Buy
+4,850
New +$77K ﹤0.01% 1760
2021
Q1
Sell
-5,700
Closed -$42K 1457
2020
Q4
$42K Hold
5,700
﹤0.01% 1761
2020
Q3
$20K Buy
+5,700
New +$20K ﹤0.01% 2080
2020
Q2
Sell
-5,700
Closed -$11K 1199
2020
Q1
$11K Hold
5,700
﹤0.01% 2163
2019
Q4
$20K Buy
5,700
+1,700
+43% +$5.97K ﹤0.01% 2005
2019
Q3
$15K Hold
4,000
﹤0.01% 1949
2019
Q2
$15K Hold
4,000
﹤0.01% 1947
2019
Q1
$33K Hold
4,000
﹤0.01% 1393
2018
Q4
$32K Sell
4,000
-500
-11% -$4K ﹤0.01% 1307
2018
Q3
$34K Hold
4,500
﹤0.01% 1370
2018
Q2
$26K Sell
4,500
-2,000
-31% -$11.6K ﹤0.01% 1449
2018
Q1
$31K Hold
6,500
﹤0.01% 1487
2017
Q4
$32K Hold
6,500
﹤0.01% 1446
2017
Q3
$34K Hold
6,500
﹤0.01% 1232
2017
Q2
$36K Hold
6,500
﹤0.01% 1155
2017
Q1
$55K Buy
+6,500
New +$55K 0.01% 963
2016
Q3
$31K Sell
7,000
-3,500
-33% -$15.5K 0.01% 1002
2016
Q2
$30K Buy
10,500
+4,600
+78% +$13.1K 0.01% 919
2016
Q1
$17K Buy
+5,900
New +$17K ﹤0.01% 937
2015
Q3
Sell
-7,303
Closed -$106K 1507
2015
Q2
$106K Buy
+7,303
New +$106K 0.03% 365
2014
Q3
Sell
-30,903
Closed -$394K 262
2014
Q2
$394K Buy
+30,903
New +$394K 0.17% 146
2014
Q1
Sell
-7,732
Closed -$59K 257
2013
Q4
$59K Buy
+7,732
New +$59K 0.03% 298